Vaccines MDPI

We are pleased to announce the successful conclusion of our special issue on "Recent Research on Human Papillomavirus (HPV) Infection and Vaccination"! With 10 insightful papers published and over 20,000 views, your engagement has been invaluable. Guest Editors: Dr. Li Shi and Yufeng Yao, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming 650118, China Read all papers here: https://lnkd.in/gJcx7pTt 🔔 Stay tuned for our upcoming second edition, where we will continue to explore this vital topic!

#GraphicalAbstractsCollection "Analyzing the In-Use Stability of mRNA-LNP COVID-19 Vaccines Comirnaty™ (Pfizer) and Spikevax™ (Moderna): A Comparative Study of the Particulate," by Jesús Hermosilla Fernández et al. This study investigates the in-use stability of clinical samples from Comirnaty™ and Spikevax™, comparing their results. Although both vaccines utilize the same mRNA-LNP technology, the findings reveal distinct differences in their particle size profiles and their responses to various handling and stress conditions. 🔗 Access the full text here: https://lnkd.in/eAKz8pEf COVID-19 vaccines; #Comirnaty™; #Spikevax™; #DLS; in-use stability testing; #TEM

🌟 New Special Issue Launched! 📙 Vaccines for the Vulnerable Population 🎓 Guest editor: Dr. My Kieu Ha, University of Antwerp This Special Issue seeks to collect contemporary information on vaccination for vulnerable populations. We invite contributions from immunology and vaccinology experts to submit their original research, reviews, perspectives, and clinical trial reports. We are particularly interested in knowledge on the following themes: 1. The pathogen- or drug-induced mechanisms that may impact vaccine responsiveness; 2. Data on the immunogenicity and safety of standard and new vaccines; 3. Identifying biomarkers that could lead to more effective vaccination strategies. 🔓 Submissions Deadline: 31 January 2026 For more information: https://lnkd.in/gEuyZxQk

New Special Issue Launched! "Immune Responses After Malaria Infection and Next Generation Malaria Vaccine" guest edited by Dr. Yu-min Chuang, Yale School of Medicine. We invite you to contribute original research, observations, or review articles that explore the following areas: 1️⃣ Immune responses during or after malaria infection; 2️⃣ Immune development and protection following vaccination; 3️⃣ Advances in the development of vaccines, including antigen discovery and innovative delivery strategies. Submissions Deadline: 31 January 2026 For more information and to submit your paper, visit: https://lnkd.in/gnwDaehN #HumoralImmuneResponse #CellularImmuneResponse #malaria #AntimalariaVaccine #Plasmodium

We are excited to announce the publication of two insightful papers in our special issue titled "Veterinary Vaccines and Host Immune Responses"! https://lnkd.in/gNCrWNyc The first paper, "Well-Being and Performance of Nursery Pigs Subjected to Different Commercial Vaccines Against Porcine Circovirus Type 2, Mycoplasma hyopneumoniae, and Lawsonia intracellularis," authored by Caio Abercio da Silva et al., explores important aspects such as biomarkers of inflammation, ileitis, piglet welfare, and post-vaccination behavior. https://lnkd.in/gYYhG_U6 The second paper, "Local Inflammatory and Systemic Antibody Responses Initiated by a First Intradermal Administration of Autogenous Salmonella-Killed Vaccines and Their Components in Pullets," by Jossie M. Santamaria, Ph.D., Chrysta Beck, and Gisela Erf, focuses on the local cellular immune response, antibody response, Salmonella vaccines, lipopolysaccharides, emulsions, and their effects on pullets. https://lnkd.in/gmqMYHjZ We are grateful to Dr. Ayumi Matsuyama and Prof. Dr. Faizal Careem for guest editing this special issue. The submission deadline is August 13, 2025. We warmly invite you to contribute your research to this important topic!

👏 Read the full text online: https://lnkd.in/gujXW2SR

We invite you to participate in 1st International Online Conference on Veterinary Sciences (#IOCVS2025), scheduled for December 3-5, 2025! Abstract submissions are due by August 4, 2025: https://lnkd.in/g3MWxjSD For more information, visit: https://lnkd.in/dPVpRdxV #Vaccine #Antivirals #Epidemiology #Microbiome #Zoonoses

New Special Issue Launched! "Bioengineering Strategies for Developing Vaccines," guest edited by Prof. Dr. Zhao Chen and Dr. Jiayi Shu, Fudan University. For this Special Issue, we are calling for research papers and reviews related to the bioengineering of vaccines, including, but not limited to, antigen engineering, vaccine platform development, vaccine delivery systems, and the application of artificial intelligence to vaccine design. We hope this Special Issue provides an opportunity to learn about updated bioengineering advances in vaccine development, both innovative methods and real-world applications, for advancing vaccine efficacy and safety. Submissions Deadline: 30 June 2025 For more information and to submit your paper, visit: https://lnkd.in/gdB-wUT4 #VaccinePlatform #AntigenDesign #TargetedDelivery #mRNA #nanoparticle #ArtificialIntelligence

#GraphicalAbstractsCollection "In Silico Analyses, Experimental Verification and Application in DNA Vaccines of Ebolavirus GP-Derived pan-MHC-II-Restricted Epitopes," by Junqi Zhang et al. The study focuses on selecting MHC-II molecules from various human leukocyte antigen superfamilies and mouse H2-I alleles, screening for high-affinity epitopes using bioinformatics tools. The analysis confirmed thirty-one HLA-II and sixty-eight H2-I restricted epitopes with significant immunogenicity and conservation. Notably, pVAX-GPEBO induced a cellular immune response, and pVAX-LAMP/GPEBO showed improved immunoprotection linked to enhanced MHC class II responses. These findings highlight promising candidate epitopes for the development of effective Ebola vaccines. Read the full text here: https://lnkd.in/gW3n6mUW #Ebola virus glycoprotein (EBOV GP); pan-MHC-II #epitope; #immunoreactivity; #InSilico analysis; #DNAvaccine; enzyme-linked immunospot (ELISpot) assay

New Special Issue Launched! "Vaccination Against Viral Hepatitis for Prevention and Treatment," guest edited by Dr. Antony Black and Dr. Monique Andersson. We welcome research contributions in the following areas: -Novel strategies to increase coverage of existing viral hepatitis vaccines; -Research into new prophylactic and therapeutic viral hepatitis vaccines, formulations, and delivery mechanisms; -Ways to enhance the immunogenicity or safety of viral hepatitis vaccines; -Immune responses to viral hepatitis vaccines; -Epidemiological impact studies of viral hepatitis vaccines. Submissions Deadline: 31 December 2025 For more information and to submit your paper, visit: https://lnkd.in/gFMWpbV8 #ViralHepatitis #vaccines #coverage #epidemiology #immunology #efficacy